by Bruce Sylvester – Elevated systolic and diastolic blood pressure appear to be predictive of different cardiovascular diseases and at different ages, researchers reported in a special themed… read more.
by Bruce Sylvester – Heart attack survivors appear to live longer by increasing dietary intake of fiber, and consumption of increased cereal fiber is especially beneficial, researchers reported… read more.
National guidelines for lipids and blood pressure are likely to be a focus of attention at this year’s meeting of the American Diabetes Association.
Pan-European Survey reveals low levels of asthma control in Ireland. Irish respondents are experiencing asthma symptoms nearly 3 days a week. 48% of Irish people with asthma are… read more.
by Bruce Sylvester – Metformin therapy at 500 twice daily (BID) is not protective against heart failure in non-diabetic patients following a heart attack, researchers reported on March… read more.
by Bruce Sylvester – Emerging uses of FDA approved drugs – Eplerenone, a drug used to reduce the risk of death in patients with heart failure, shows significant… read more.
by Bruce Sylvester – Emerging uses of FDA-approved drugs – Treatment with acetazolamide plus a low-sodium weight-reduction diet for patients diagnosed with idiopathic intracranial hypertension (IIH)mand mild vision… read more.
by Bruce Sylvester – A 15% drop in dietary salt use from 2003-2011 in England and a 40% drop in deaths from heart disease and stroke during the… read more.
by Bruce Sylvester – Researchers report that administering blood pressure lowering drugs to patients in the first 48 hours after a stroke does not lower the risk of… read more.
by Bruce Sylvester – On March 29, 2014, investigators presented results from three separate evolocumab trials at the American College of Cardiology annual meeting/ACC2014. Evolocumab is a human… read more.
by Bruce Sylvester – Post non-cardiac surgery treatment with low-dose clonidine increased rates of clinically important hypotension and non-fatal cardiac arrest, researchers from the POISE-2 trial have reported.
by Bruce Sylvester – Severe aortic stenosis patients undergoing transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis have achieved a significantly higher rate of survival at one… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
